Current Therapy in Nephrology: Proceedings of the 2nd International Meeting on Current Therapy in Nephrology Sorrento, Italy, May 22–25, 1988

Front Matter....Pages I-XVII
Front Matter....Pages 1-1
Cell Mediated Immunity in Glomerulonephritis: Prospects for Treatment....Pages 3-10
Enzyme Therapy of Experimental Glomerulonephritis....Pages 11-16
DNA Antibodies and Idiotypes....Pages 17-21
Reduction of Protein Excretion by Allopurinol in Rats with Adriamycin Nephrosis....Pages 22-24
Clinical Experience with an Antithrombotic Agent (Defibrotide) in Glomerular Diseases. Preliminary Results....Pages 25-27
Defibrination with Ancrod in Crescentic Glomerular Lesions: Preliminary Observation....Pages 28-30
PAF Induced Glomerular and Vascular Alterations in the Isolated Perfused Rat Kidney....Pages 31-33
Histogenesis of Glomerular Crescents in Idiopathic Proliferative Extracapillary Glomerulonephritis. Clinical Aspects....Pages 34-36
Premises for an Antioxidant Therapy in Pregnancy Induced Nephropathy....Pages 37-39
Pulse Therapy with Cyclophosphamide in Primary and Sistemic Glomerulopathy Resistant to Steroid Treatment....Pages 40-42
Clinical Presentation of IgA Nephropathy in Southern Italy....Pages 45-48
Interleukin-2 Production and Abnormalities of Immune Regulation in Patients with Primary IgA Nephropathy....Pages 49-52
In-Vitro Study of T Lymphocyte Activation in IgA Nephropathy (GN)....Pages 53-55
HLA Class II Histoglobulins Involvement in Mesangial IgA Glomerulonephritis (Berger’s Disease)....Pages 56-58
Variations in T Lymphocyte Subsets in IgA Nephropathy....Pages 59-61
Acute Renal Failure (ARF) As Expression of a IqA Nephropathy (IqAN)....Pages 62-64
Abnormal Intestinal Permeability in IgA Nephropathy....Pages 65-67
Efficiency and Tolerance of Cyclosporine Treatment in Adult Nephrosis....Pages 71-75
Ciclosporine Treatment of Childhood Idiopathic Neprhosis....Pages 76-80
Acute Renal Effects of Intravenous High Dose Methylprednisolone (P) Therapy in Nephrotic Syndromes....Pages 81-83
Front Matter....Pages 1-1
Should Steroid Therapy be Used in Nephrotic Syndrome [NS] Related to Hepatitis B Virus [HBV] Associated Nephritis?....Pages 84-86
Ciclosporin a Therapy in Nephrotic Adults....Pages 87-90
Cyclosporine Effect on Corticoresistant Nephrotic Syndrome in Primary Glomerulonephritis....Pages 91-93
Effects of Cyclosporine a on Renal Function and Proteinuria in Patients with Nephrotic Syndrome after a Single Oral Administration....Pages 94-98
Cyclosporine a Therapy in Idiopathic Nephrotic Syndrome....Pages 99-101
Captopril as an Antiproteinuric Agent in Patients with Chronic Glomerulonephritis....Pages 102-104
Steroid-Resistant Nephrotic Syndrome Treated with Cyclosporin A(CyA)....Pages 105-107
Intravascular Volume Expansion as Therapeutic Approach to the Underfill State of Preeclampsia....Pages 111-113
A Prospective Randomized Therapeutic Trial for Schistosomal Specific Nephropathy....Pages 114-116
Immunotactoid Glomerulopathy: What about Therapy?....Pages 117-119
Renal Presentation is Not a Relevant Factor in Predicting Renal Outcome in Patients with Systemic Lupus....Pages 120-123
Is Tubulointerstitial Damage a Reliable Index for Predicting Renal Outcome in Primary Membranous Nephropathy?....Pages 124-127
Serum IgA in Children with Acute Post-Infectious Glomerulonephritis....Pages 128-130
Epidemiology of Idiopathic Glomerular Disease in a French Area: A Prospective Study....Pages 131-133
Front Matter....Pages 135-135
Clinical course of rapidly progressive glomerulonephritis during immunosuppressive therapy, plasmaexchange and without specific therapy....Pages 137-140
Plasma Exchange in Treatment of Acute Vascular Rejection....Pages 141-143
Evaluation of Plasma Exchange Effect in Patients with Lung Hemorrhage and Rapidly Progressive Glomerulonephritis Either Idiopathic or Vasculitis Associated....Pages 144-146
Current Treatment of Acute Renal Failure(ARF) from Leptospirosis....Pages 147-149
Plasmaexchange Induced Improvement on Extra-Renal Manifestations of Systemic Lupus Erythematosus....Pages 150-152
Feasibility of an Integrated Diet-Dialysis Program (IDDP) as a Treatment of ESRD....Pages 155-157
Front Matter....Pages 135-135
Treatment of Uremic Anemia with Etretinate: Comparison with Recombinant Human Erythropoietin (rHuEPO)....Pages 158-160
Acute Effects of Carnitine Addition to the Dialysis Fluid During Hemodialysis in Patients with Chronic Renal Failure....Pages 161-163
Clonidine is Effective in the Treatment of “Restless Legs” Syndrome in Chronic Uremic Patients....Pages 164-166
Hemorheology and Hypertension in End-Stage Renal Failure Patients Treated with Erythropoietin....Pages 167-169
Effects of Chronic Hyperproteic Diet on Renal Function and Albumin Excretion....Pages 170-172
ACE Inhibition and Progression of Renal Injury in Man....Pages 173-175
One Year Experience with Hypoproteic Diet and Once a Week Hemodialysis (Less than 5 Hours)....Pages 176-178
Calcitriol and Renal Failure....Pages 179-181
Torasemide, a Loop Diuretic, Useful in Correcting ECF Volume Expansion in Patients with Chronic Renal Failure....Pages 182-184
Treatment of Rapidly Progressive Lupus Glomerulonephritis....Pages 187-189
The Effect of a Single Perinatal Treatment with Captopril on Cytotoxicity in Rats....Pages 190-192
New Evidence for the Neurotoxicity of PTH in Uremia....Pages 193-195
Connection between Chronic Renal Insufficiency and Alluvial Soils in Central Greece....Pages 196-198
Front Matter....Pages 199-199
Clearances of Small Solutes in Hemodiafiltration and Paired Filtration Dialysis....Pages 201-203
L-Carnitine Addition in the Dialysis Fluid: A New Therapeutical Approach for Hemodialysis Patients....Pages 204-206
Bidirectional Blood-Pump with a Bidirectional Blood-Passage through the Artificial Kidney....Pages 207-210
Hemodialysis with Low Flow of Sterile Dialysate (LSDH). Experience of Two Years....Pages 211-213
Continuous Veno-Venous Hemofiltration (CVVH) for Hemodynamic Stabilization by Blood Cooling in Septic Shock....Pages 214-216
Blood Volume Changes During Hemodialysis Detected by Conductivity Measurements....Pages 217-219
A New Hemodialysis Single Patient Unit in the Short Dialysis Treatments....Pages 220-222
Front Matter....Pages 199-199
Paired Filtration Dialysis (PFD): Better Purification than Conventional Hemodialysis (HD)....Pages 223-225
Modification of Biohumoral and Electromyografic Features Patients on PFD: 12 Months Follow-Up Results....Pages 226-228
Restoration of the Strength of ESRF Patients by PFD....Pages 229-231
Relation Between Red Blood Cell Function and β2-Microglobulin Concentration in Hemodialysis....Pages 235-238
Beta-2-Microglobulin (B2m) Adsorption on Activated Charcoal (AC)....Pages 239-241
Clinical Characteristics of Beta 2 Microglobulin Associated Amyloidosis in Chronic Haemodialysis Patients....Pages 242-244
Plasma B 2 -Microglobullin (B 2 M) Changes Induced by Different Dialysis Membranes....Pages 245-247
Intradialytic Behaviour of β-2-Microglobulin During Acetate Dialysis (HDac), Biofiltration (BF) and Paired Filtration Dialysis (PFD)....Pages 248-250
In Vitro Influence of Six Dialysis Membranes on Beta-2-Microglobulin Behaviour....Pages 251-253
Behaviour of Beta2microglobulin in CRF Patients Starting Blood Purification....Pages 254-256
Standards for Nutritional Assessment in Dialysis....Pages 259-271
Is Malnutrition a Clinically Evident Condition in Patients Undergoing Hemodialysis?....Pages 272-274
Serum Branch-Chain Amino and Keto Acids in the Nutritional and Immunological Assessment of Uremics on Conservative and Dialysis Treatment....Pages 275-277
Nutritional Abnormalities as a Guide to Prognosis in Hemodialized (HD) Patients (PTS)....Pages 278-280
Relationship Between Physical Activity and Nutritional Status in Patients on Maintenance Hemodialysis....Pages 281-283
Risk Factors of Malnutrition in RDT Patients....Pages 284-286
Dietetic Supplements in Malnourished Patients Undergoing Chronic Hemodialysis....Pages 287-289
Clinical Aspects of Hemodialysis Biocompatibility....Pages 293-297
Cellular Aspects of Biocompatibility....Pages 298-302
Hemodialysis-Associated Neutrophil Abnormalities and Generation of Leukotriene B 4 ....Pages 303-305
Front Matter....Pages 199-199
Criteria for Adequate Hemodialysis....Pages 329-333
Dialytic Adequacy of Different Replacement Treatments....Pages 334-336
Routine Evaluation of Kt/V and Protein Catabolic Rate....Pages 337-339
Adequacy of Biofiltration: A Comparative Study with Standard Acetate Hemodialysis....Pages 340-342
Is it Possible a Mathematical Verification of Kt/V ?....Pages 343-345
Adequacy of Dialysis and Prolonged Reuse....Pages 346-348
Oxalate Clearance by High Flux Haemodialysis Using Polyacrylonitrile Membranes....Pages 379-381
An Immunohistochemical Technique for the Study of Plasma Proteins Adsorbed on Dialysis Membranes....Pages 306-308
Adsorption of Anaphylatoxins C3a and C5a on An-69 and Polysulfone Membranes of Dialyzer — In Vivo Study....Pages 309-311
Blood Cooling Prevents Degranulation of Neutrophils During Hemodialysis....Pages 312-314
Long Term Effects of Blood-Material Interactions....Pages 315-317
Blood Concentration of Plasticizer at Steady-State in Dialysing Patients: A Model....Pages 318-323
IgE Ethylene Antioxide and Eosinophilia Dialysis....Pages 324-326
Positive Acid Balance in Patients Undergoing Chronic Hemofiltration....Pages 351-353
Trends of BUN and Acid-Base Status During High Efficiency Hemodialysis....Pages 354-356
Clinical Results of Acetate Free Biofiltration (AFB). Two Years Experience....Pages 357-359
Successfull Treatment with Bicarbonate Dialysis (BD) of Severe Lactic Acidosis in Phenformin Treated Patients on Dialytic Treatment (DT)....Pages 360-363
Metabolic Assessment of Acetate-Free Biofiltration (AFBF)....Pages 364-366
Bicarbonate and Calcium Balance in Postdilutional Hemodiafiltration....Pages 367-369
Intra-Arterial Digital Subtraction Angiography (aDSA) for Evaluation of AV-Fistulas in Hemodialysis Patients....Pages 373-375
Front Matter....Pages 199-199
Technical and Clinical Evaluation of a New Low Flux Polysulphon Membrane....Pages 382-384
Ultrafiltration Control in Short Time Dialysis....Pages 385-387
Red Cell Fragmentation (RCF) Syndrome in Chronic Single Needle Dialysis....Pages 388-391
Hypotension and Cardiac Arrhythmias: A Consequence of Left Ventricular Hypertrophy in Dialysis....Pages 392-394
One Year Experience with Short Dialisys Using a High Efficiency Dialyzer....Pages 395-397
The Influence of Nifedipine on Serum Lipids in Elderly Chronic Dialysis Patients....Pages 398-400
Effect of Dialysate Calcium Concentration Changes on Plasma Calcium and PTH in Dialysis Patients Treated with Calcium Carbonate as a Phosphate Binder....Pages 401-403
Cerebral Atrophy in Long-Term Haemodialyzed Patients....Pages 404-406
Beneficial Effect of Desferrioxamine on the Anaemia of a Haemodialysis Patient without Aluminium or Iron Overlaod....Pages 407-409
Transient Erythrocyte Volume (MCV) Increase in Hemodialysis....Pages 410-412
Assessment of Liver Ability to Biotransformation of Antipyrine in Uraemic Patients on Regular Peritoneal Dialysis Treatment....Pages 413-415
Clinical Pitfalls of Short-Term Dialysis....Pages 416-418
Farmacokinetics of Chlordesmethyldiazepam in Patients on Regular Hemodialysis....Pages 419-422
Effect of Polyacrylonitrile Membrane Upon Plasma Osteocalcin and iPTH Levels in Patients on Maintenance Hemodialysis....Pages 423-425
Abdominal Hernias as Complication of C.A.P.D.: Importance of the Early Diagnose and Surgery....Pages 426-428
Hemodialysis in the Elderly....Pages 429-431
Front Matter....Pages 433-433
Age and Renal Transplantation....Pages 435-438
Influence of Recipient Age on the Outcome of Cadaver Kidney Transplantation in Patients Treated with Cyclosporine (CyA)....Pages 439-443
Renal Replacement Therapy (RRT) in Patients Over 60 Years of Age and the Use of Elderly Living Donors....Pages 444-448
Impact of Donor Age in Relation with Graft Survival and Quality of Remaining Kidney of Donor....Pages 449-451
Front Matter....Pages 433-433
Is Age Over 55 Years Risk Factor for Kidney Donor and for Graft Function in Living Related Renal Transplantation?....Pages 452-454
Renal Transplantation in Patients Aged Over 50 Years....Pages 455-457
Kidney Transplantation at an Advanced Age....Pages 458-460
Cadaveric Renal Transplantation in the Elderly....Pages 461-467
Renal Transplantation in Elderly Recipients....Pages 468-470
Renal Transplantation with Elderly Donor....Pages 471-473
Calcium Antagonists Prevent Lymphocyte Activation in Kidney Allograft Recipients....Pages 477-479
A Prospective Randomized Study of the Portective Effect of Verapamil on the Ischaemic Renal Injury in Renal Allotransplants....Pages 480-482
Effects of Systemic Administration of the Pge-1 Analogue Alprostadil in the Early Phase of Renal Transplantation....Pages 483-485
Interleukin-2 (IL2) Production by Peripheral Blood Lymphocytes (PBLS) in the Diagnosis of Renal Allograft Rejection (R) in Cyclosporin (CsA) Treated Patients....Pages 486-486
Changes of Anti-Thrombin III (AT III), Protein C (PC), and Protein S (PS) in Renal Transplantation....Pages 487-489
Kaposi’s Sarcoma After Kidney Transplantation, An Etiologic Study and Successful Treatment....Pages 490-492
Renal Arterial Stenosis in Renal Transplantation: A Mathematical Pathogenetic Hypothesis and Its Possible Clinical Implications....Pages 493-495
“Renal Functional Reserve” in Renal Transplant Patients on Cyclosporine Therapy....Pages 496-499
Front Matter....Pages 501-501
Sandimmun ® /An Appraisal of Drug Interactions....Pages 503-518
Drug Interaction Between Cyclosporin A and Macrolides Antibiotics : Study in Vitro and In Vivo....Pages 519-522
Interaction of Calcium Antagonists and Ciclosporine A....Pages 523-528
Cyclosporin A — H2 Receptor Antagonists Drug Interaction in the Sprague-Dawley Rat....Pages 529-531
Cyclosporin A (CSA) Drug Interactions....Pages 532-534
Cyclosporine A + Glybenclamide. Effect on Glucose Metabolism: Preliminary Results....Pages 535-537
Front Matter....Pages 501-501
Acute Cyclosporine a Nephrotoxicity....Pages 541-550
Renal Pathology After Low Dose Cyclosporine (CyA) in Patients with Primary Sjogren’s Syndrome....Pages 551-553
The Influence of Cyclosporin on Cytomegalovirus-Related Kidney Graft Survival....Pages 554-556
Kaposi’s Sarcoma in Kidney Graft Recipients Treated with Low Doses of Cyclosporine....Pages 557-559
A Cellular Mechanism for Cyclosporine A-Induced Nephrotoxicity....Pages 560-562
Dopamine (D) Reverses Acute Cyclosporine A (CyA) Nephrotoxicity. Micropuncture Study in the Rat....Pages 563-565
Reversibility of Acute Cyclosporine Renal Impairment by Dopamine in Healthy Subjects....Pages 566-568
Relation Between Gengival Overgrowth and Cyclosporin (CyA) Blood Levels in Renal Transplanted Patients....Pages 569-572
Back Matter....Pages 573-582